Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,718 | 233 | 97.9% |
| Education | $103.40 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $492.84 | 28 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $484.95 | 37 | $0 (2024) |
| Amgen Inc. | $481.86 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $437.67 | 25 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $351.24 | 15 | $0 (2024) |
| Horizon Therapeutics plc | $252.39 | 14 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $215.62 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $210.67 | 10 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $210.25 | 10 | $0 (2024) |
| Travere Therapeutics, Inc. | $201.56 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,157 | 54 | Amgen Inc. ($248.14) |
| 2023 | $1,044 | 56 | Bayer Healthcare Pharmaceuticals Inc. ($165.81) |
| 2022 | $1,029 | 57 | Bayer HealthCare Pharmaceuticals Inc. ($187.50) |
| 2021 | $602.85 | 32 | Mallinckrodt Hospital Products Inc. ($123.01) |
| 2020 | $305.13 | 17 | AstraZeneca Pharmaceuticals LP ($60.58) |
| 2019 | $583.40 | 18 | GlaxoSmithKline, LLC. ($111.65) |
| 2018 | $100.39 | 1 | Otsuka America Pharmaceutical, Inc. ($100.39) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Nephrology | ||||||
| 10/22/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEPHROLOGY | ||||||
| 10/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.37 | General |
| 10/03/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Cardio-renal | ||||||
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 09/26/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Nephrology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: NEPHROLOGY | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/30/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: CRITICAL CARE | ||||||
| 08/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Nephrology | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Immunology | ||||||
| 08/13/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 673 | 1,393 | $514,590 | $153,307 |
| 2022 | 11 | 705 | 1,468 | $507,078 | $145,267 |
| 2021 | 13 | 789 | 1,578 | $582,733 | $179,606 |
| 2020 | 11 | 726 | 1,566 | $427,132 | $130,831 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 26 | 160 | $145,016 | $44,412 | 30.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 407 | $73,138 | $24,411 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 230 | $75,440 | $20,208 | 26.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 119 | 142 | $71,102 | $18,761 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 152 | $39,248 | $13,455 | 34.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 14 | 54 | $40,464 | $12,316 | 30.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 30 | $22,506 | $7,055 | 31.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 46 | 98 | $17,953 | $5,344 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 69 | $15,951 | $3,557 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $11,470 | $2,885 | 25.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 24 | $2,303 | $902.16 | 39.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 28 | 140 | $126,889 | $36,527 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 156 | 479 | $86,076 | $25,370 | 29.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 111 | 124 | $62,089 | $18,337 | 29.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 21 | 78 | $58,448 | $17,203 | 29.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 99 | 218 | $56,290 | $16,659 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 134 | $43,952 | $11,066 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 125 | $28,896 | $7,499 | 26.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 40 | 78 | $14,289 | $4,284 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $14,019 | $3,650 | 26.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 11 | 16 | $12,003 | $3,430 | 28.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 34 | 43 | $4,126 | $1,240 | 30.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 31 | 212 | $174,688 | $57,572 | 33.0% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 18 | 103 | $71,138 | $21,966 | 30.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 181 | 400 | $73,043 | $21,880 | 30.0% |
About Dr. Samardia Missick, MD
Dr. Samardia Missick, MD is a Nephrology healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1720498777.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samardia Missick, MD has received a total of $4,822 in payments from pharmaceutical and medical device companies, with $1,157 received in 2024. These payments were reported across 235 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,718).
As a Medicare-enrolled provider, Missick has provided services to 2,893 Medicare beneficiaries, totaling 6,005 services with total Medicare billing of $609,011. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Johnson City, TN
- Active Since 04/30/2014
- Last Updated 08/01/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1720498777
Products in Payments
- KRYSTEXXA (Biological) $475.48
- Kerendia (Drug) $474.61
- RAYALDEE (Drug) $420.16
- ACTHAR (Biological) $261.73
- LUPKYNIS (Drug) $210.25
- JYNARQUE (Drug) $203.11
- LOKELMA (Drug) $200.87
- INJECTAFER (Drug) $169.53
- BENLYSTA (Biological) $164.81
- FARXIGA (Drug) $147.68
- Veltassa (Drug) $144.00
- Velphoro (Drug) $143.92
- ULTOMIRIS (Biological) $119.69
- Parsabiv (Drug) $108.89
- Auryxia (Drug) $108.17
- TERLIVAZ (Drug) $97.47
- LIBERTY SELECT CYCLER (Device) $95.13
- Renal - PD (Device) $85.94
- AURYXIA (Drug) $74.05
- TARPEYO (Drug) $73.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Johnson City
Dr. Martin Tran, D.o, D.O
Nephrology — Payments: $8,595
Ms. Cynthia Marsh, Np, NP
Nephrology — Payments: $6,935
Muhammad Owais Malik, Md, MD
Nephrology — Payments: $1,986
Dr. Leslie Panus, M.d, M.D
Nephrology — Payments: $17.76
Dr. Stanley Vermillion, Md, MD
Nephrology — Payments: $15.70